A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents

Retrospective medical records review (n=234) found methotrexate (MTX) & biologics (BGs) appear to be linked to improvement in paediatric psoriasis, although BGs seem to be linked to greater reduction in severity scores and higher drug survival rates than MTX in real-world setting

JAMA Dermatology